BackNeuBase Therapeutics Overview

NeuBase Therapeutics Research & Development

Research & Development expenses for NBSE.

Quarterly R&D Expenses

$387564.00
↓ 92.94% YoY

As of Sep 30, 2023

Annual R&D Expenses (TTM)

$4.26M
↓ 80.12% YoY

Trailing 12 months ending Sep 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin